- Cipla has informed BSE about the outcome of the USFDA inspection at its Bommasandra manufacturing facility.
- The inspection took place from 26th to 30th May, 2025.
- The USFDA ha…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]